Skip to Navigation Skip to Search Skip to Content
Search All Centers

Inside the First FDA-Approved CAR-T Cell Therapy

Published on October 25, 2017

The first CAR-T cell therapy to receive FDA approval, CTL019 (Kymriah) was recently approved for children and young adults with B-cell acute lymphoblastic leukemia (ALL) that is refractory or has relapsed at least twice. Expert Dr. Michael Deinginger joins Patient Power Founder Andrew Schorr to explain CAR T-cell therapy, an approach that uses the body’s own system to fight the disease. Find out why Dr. Deininger calls this approval “revolutionary.”

Featuring

Your site is AWESOME! Thank you all so much for this incredible resource to families who are in crisis/affected by cancer.

— Loyal Patient Power viewer

You might also like